Page 2 - நாசி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from நாசி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In நாசி Today - Breaking & Trending Today
Saving lives and supporting recovery from addiction Alberta’s government is opening more medical detox beds and offering nasal naloxone kits in Edmonton as part of its ongoing work to save lives and increase access to recovery supports. Some parts of this page will not display. JavaScript is not available in this browser or may be turned off. With $2.1 million from the government over three years, Edmonton’s George Spady Society now has 35 medical detox beds. Another $1.5 million from the provincial government is supporting a pilot project to provide Albertans in the Edmonton area with publicly funded nasal naloxone kits. The project is being led by the George Spady Society, in collaboration with Alberta Health Services, Edmonton Police Services and other community partners. ....
MOSCOW. KAZINFORM - Russia may register a nasal vaccine against COVID-19 developed by the Gamaleya Research Center for Epidemiology and Microbiology in 2022, if the clinical trials planned for 2021-2022 are successful, head of the center Alexander Ginzburg told TASS. ....
12 maggio 2021 16:52 Fonte: Adnkronos #salute-e-benessere Product recently cleared in EU as Class III medical device BALERNA, Switzerland, May 12, 2021 /PRNewswire/ APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Prof. Giancarlo Icardi as lead investigator. The study is planned to enroll a total of 57 COVID-19 patients who show mild symptoms of the disease and is evaluating the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. Resul ....
In a new study published in the journal JAMA Otolaryngology–Head & Neck Surgery, a group of Finnish researchers from the Helsinki University Hospital and University of Helsinki, investigated the frequency and type of complications that have arose following a Covid-19 nasal swab test ....